SAN DIEGO – Confirming the explosive growth of the life science industry in San Diego, California, JLL announced today that Neurocrine Biosciences, Inc., a neuroscience-focused, biopharmaceutical company, has signed a lease at Aperture Del Mar. The lease includes four buildings, totaling 535,000-square-feet of Class A life science and office space on 15.72 acres in a coastal setting in the Del Mar Heights submarket. The local San Diego company will relocate its headquarters from 12780 El Camino Real, and begin to move into the new campus in 2023.
For three decades, Neurocrine Biosciences, one of San Diego’s largest life sciences companies, has applied its unique insights into neuroscience to advance medicines for neurological, neuroendocrine, and neuropsychiatric disorders. It has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.
“Aperture is the perfect fit for Neurocrine Biosciences’ future headquarters, said Matt Abernethy, Chief Financial Officer of Neurocrine Biosciences. “The site will enable us to more than double our lab space, supporting our focus on developing therapies that relieve suffering for people with great needs, but few treatment options.”
JLL’s team of Chad Urie and Grant Schoneman represented Neurocrine Biosciences in one of the largest leases in San Diego’s history. Gemdale USA Corporation is the owner and developer of Aperture Del Mar and was represented by JLL’s Tony Russell.
“We are fortunate to be able to partner with a company like Neurocrine Biosciences, that is advancing medicines for neurological, neuroendocrine, and neuropsychiatric disorder,” said Chad Urie, JLL Executive Managing Director. “This was obviously a project of significant magnitude that required considerable attention. I am glad we were able to execute what I think is a fantastic deal structure for Neurocrine.”
Schoneman continued by saying “This lease is another step to paving the way for the advancement of life sciences in San Diego, and represents Neurocrine Bioscience’s commitment to the local sector as one of its largest employers” said Grant Schoneman, JLL Executive Managing Director.
Gemdale USA Corporation acquired the property from Lincoln Property Company in October 2019 with development beginning a month later. Phase 1 of Aperture Del Mar, including the parking structure, was completed in November 2021.
“Long before our lease with Neurocrine Biosciences, we had a vision to go spec for Phase 1 of this property, believing in the strength of this market,” said Josh Goldman, Managing Director, Development at Gemdale USA Corporation. “Neurocrine Biosciences is the perfect tenant for Aperture Del Mar with its history in San Diego and continued growth in the biopharmaceutical industry.”
When complete, Neurocrine Biosciences will occupy four office and research buildings totaling 535,000 square feet and has the option to expand into a fifth building which can offer up to another 125,000 square feet. Phase 1 of campus was designed by the world’s largest architecture firm, Gensler, offering a culmination of multiple architectural styles that features superior connectivity between each building and floor, as well as the outdoor environment. It was designed to streamline routines, eliminate distractions, and stimulate the creative thinking that sparks breakthroughs. Multiple balconies, pocket doors and exterior stairwells create collision points in a central promenade to curate the ultimate user experience. Additionally, each building features 15-foot clear height, open and flexible floorplates and floor-to-ceiling glass that creates abundant natural light and panoramic views. This unique setting, featuring unobstructed view corridors, is centered around programmed gathering areas, on-site and off-site amenities, trails and parks for today’s workforce. The outdoor spaces blend seamlessly with the indoor spaces and feature a boutique coffee roaster, event lawn, sports courts, walking paths, dog park, amphitheater, fitness areas and gym with spa-like showers and lockers.
About JLL
JLL (NYSE: JLL) is a leading professional services firm that specializes in real estate and investment management. JLL shapes the future of real estate for a better world by using the most advanced technology to create rewarding opportunities, amazing spaces and sustainable real estate solutions for our clients, our people and our communities. JLL is a Fortune 500 company with annual revenue of $19.4 billion in 2021, operations in over 80 countries and a global workforce more than 98,000 as of December 31, 2021. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.
